Found: 13
Select item for more details and to access through your institution.
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 2, p. 207, doi. 10.1093/cid/ciy881
- By:
- Publication type:
- Article
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 8, p. 1006, doi. 10.1093/cid/cix015
- By:
- Publication type:
- Article
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 1, p. 118, doi. 10.1093/jac/dkp412
- By:
- Publication type:
- Article
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 3, p. 456, doi. 10.1093/jac/dkn234
- By:
- Publication type:
- Article
HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program.
- Published in:
- PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0117430
- By:
- Publication type:
- Article
Genome-Wide Association Study of HIV Whole Genome Sequences Validated using Drug Resistance.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163746
- By:
- Publication type:
- Article
T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009871
- By:
- Publication type:
- Article
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases.
- Published in:
- Journal of Medical Virology, 2008, v. 80, n. 5, p. 754, doi. 10.1002/jmv.21169
- By:
- Publication type:
- Article
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. 473, doi. 10.1093/jac/dky428
- By:
- Publication type:
- Article
Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article